Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
- Fabricant: Dewael
- Essai de produit: 99%+
- Apparence:Poudre blanche lyophilisée
- Lieu d'origine: Chine
- certificat: SGS,ISO9001, GMP
- Quantité minimum d'achat: 100ml
- Détails de l'' emballage: des moyens discrets d'emballage pour la douane passer garanti
- Heure de livraison: Dans 12 heures après réception de votre paiement
- Modalités de paiement: Western union, MoneyGram,Bitcoin,Virement
- livraison: EMS,DHL,Fedex,UPS,TNT et ainsi de suite.
- Politique: Re-Politique de livraison
- Capacité d'approvisionnement: 500-600Litres / mois
Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
Nafarelin Acetate (synarel) Détails:
Nom du produit | Nafarelin Acetate |
CAS NO. | 76932-56-4 |
Synonymes | Nafarelin Acetate |
Catégorie | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Produits chimiques fins. |
Pureté | 99% Nafarelin Acetate |
Apparence | Nafarelin Acetate powder |
Durée de conservation | 2 years for Nafarelin Acetate |
Usage | Nafarelin Acetate is used in female infertility and endometriosis. |
Espace de rangement | Nafarelin Acetate should be stored in a well-closed containerat low temperature, keep away from moisture, heat and light. |
La description
Its proposed mechanism of action could be the desensitization of pituitary GnRH receptors resulting in a decrease in gonadotropin release, and ovarian hormone serum concentrations much like those achieved in postmenopausal women. Nafarelin is administered by nasal inhalation and contains been generally well tolerated. It is associated with a high incidence of adverse effects but they are rarely severe enough to cause withdrawal from treatment, the ones occurring most frequently–hot flashes, vaginal dryness, and decreased libido–are a result of the hypoestrogenemia induced through the drug. Increased bone turnover is situated women on nafarelin but biochemical parameters resume pretreatment concentrations by six months after termination of treatment. This agent’s invest the therapy of endometriosis will be determined as clinical experience accumulates.
Nafarelin Acetate Application:
Treating endometriosis, including relieving pain and reducing lesions. It is usually used to treat early puberty (central precocious puberty [CPP]) in children of both sexes. It could be used for other difficulties as determined by your doctor.
Nafarelin is really a gonadotropin-releasing hormone (GnRH) agonist. It functions by decreasing creation of certain steroids in your body, which decreases the symptoms of endometriosis or early puberty.
COA
Item | spécification | Result |
Apparence | poudre blanche | Conforme |
Identification | Positif | Conforme |
Essai | 98.0% min | 98.2% |
Loss on Drying | 6.0%maximum. | 5.8% |
contenu acétate(par HPLC) | 10.0%maximum. | 9.8% |
Contenu Peptide (N%) | 80.0%min. | 88.0% |
Composition en acides aminés | ± 10% de la théorie | Conforme |
impuretés unique (HPLC) | 1.0%maximum. | 0.45% |
MME(ESI) | Cohérent | Conforme |
Équilibre de la masse | 95.0~ 105,0% | 98.0% |
———————————————————————————————————————————————————————————————————————————————————————-
Contacter maintenant
Avis
Il n'y a pas encore de critiques.